Samantha B. is an accomplished leader in the biotechnology and life sciences sectors, currently serving as an Independent Board Director for ALZpath Inc. and Draig Therapeutics, where Samantha contributes to advancing diagnostic tools for Alzheimer’s disease and next-generation treatments for neuropsychiatric disorders, respectively. Additionally, Samantha holds the position of Venture Partner in the Life Sciences Investment Team at Intermediate Capital Group and acts as Chief Medical Officer at Enigma Biomedical USA. With extensive experience in clinical development, particularly with Biogen and AstraZeneca, alongside a strong academic background including a PhD in Biochemistry from the University of Dundee and a postdoctoral fellowship at Harvard Medical School, Samantha has also been an active member of multiple boards, including Vigil Neuroscience and The Boston Home.
This person is not in the org chart
This person is not in any offices